Disease Areas
Diabetes
Obesity
Cardiovascular Disease (CVD)
Chronic Kidney Disease (CKD)
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Neurodegenerative Diseases
Haemophilia
Sickle Cell Disease
Primary Hyperoxaluria
Growth Hormone Disorders
Hormone Replacement Therapy
Congresses
Scientific Publications
IME
Search Science Hub
Register
Login
My Account
Welcome to Novo Nordisk Science Hub
Are you a healthcare professional?
No
Yes
Congresses
PES 2026
Real-world comparison of long-acting vs. short-acting growth hormone therapy in pediatric patients with growth hormone deficiency in the United States
PES 2026
Pediatric Endocrine Society (PES 2026)
30 April - 3 May 2026
Real-world comparison of long-acting vs. short-acting growth hormone therapy in pediatric patients with growth hormone deficiency in the United States
Authors
:
Jing Voon Chen
1
, Nicky Kelepouris
1
, Catherine Park
2
, Xinshuo Ma
2
, Xiyuan Wu
2
, Bradley S Miller
3
Affiliations
View Details
Hide Details
Download poster (.pdf)
Share
Copy link
{{pageUrl}}
Keywords
Rare Endocrine Disorder
Congress poster